After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, STIM falls under the Healthcare sector while operating within the Medical Devices industry segment. The current market capitalization of Neuronetics Inc is $188.46M. A total of 1.44 million shares were traded on the day, compared to an average of 1.30M shares.
In the most recent transaction, Madryn Asset Management, LP sold 3,500,000 shares of STIM for 3.72 per share on Aug 08 ’25. After the transaction, the 10% Owner now owns 1,142,351 company shares. In a previous transaction on Aug 08 ’25, MADRYN HEALTH PRTS II (CAY MAS bought 2,925,554 shares at 3.72 per share.
Among the insiders who bought shares, MADRYN HEALTH PARTNERS II, LP acquired of 192,806 shares on Aug 08 ’25 at a per-share price of $3.72. In another insider transaction, MADRYN SELECT OPPORTUNITIES, L bought 381,640 shares at $3.72 per share on Aug 08 ’25.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, STIM has a high of $5.92 and a low of $0.52.
As of this writing, STIM has an earnings estimate of -$0.12 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.11 per share and a lower estimate of -$0.13. The company reported an EPS of -$0.44 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. STIM’s latest balance sheet shows that the firm has $96.34M in Cash & Short Term Investments as of fiscal 2021. There were $39.54M in debt and $15.70M in liabilities at the time. Its Book Value Per Share was $0.41, while its Total Shareholder’s Equity was $85.17M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for STIM is Buy with a score of 4.50.
